Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

17 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Multiple Myeloma NCT00781170

- 2016-01-24 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00781170

Eligibility Leukemia NCT00027560

- 2016-07-24 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00027560

Eligibility Acute Leukemia NCT01020175

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01020175

Eligibility Acute Lymphoblastic Leukemia NCT01744223

- 2015-12-21 - 1 Formulär, 2 Item-grupper, 15 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT01744223

Eligibility Acute Lymphoblastic Leukemia NCT00529360

- 2015-12-21 - 1 Formulär, 2 Item-grupper, 15 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL; ODM derived from: https://clinicaltrials.gov/show/NCT00529360

Eligibility Acute Lymphoblastic Leukemia NCT00861679

- 2015-12-21 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International; ODM derived from: https://clinicaltrials.gov/show/NCT00861679

Eligibility Acute Lymphoblastic Leukemia NCT00368355

- 2015-12-21 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts; ODM derived from: https://clinicaltrials.gov/show/NCT00368355

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients NCT00180102 - nach 2. Induktionstherapie

- 2021-09-27 - 25 Formulär, 8 Item-grupper, 84 Dataelement, 1 Språk
Item-grupper: Shipping of Material, Blood count, Clinical Chemistry, Bone Marrow Morphology, Treatment outcome evaluation, Risk group, Planned first post remission treatment, Planned first post remission treatment
NCT00180102 AML2003 is a prospective randomized trial, to investigate the value of early allogeneic stem cell transplantation in aplasia after induction therapy for high risk patients with acute myeloid leukemia. Phase 4 Study Type:Interventional Study Design:Allocation: Randomized Intervention Model:Factorial Assignment Masking:None (Open Label) Primary Purpose:Treatment Medical Department I, University Hospital Carl Gustav Carus Dresden, Germany, 01307 Sponsors and Collaborators Technische Universität Dresden Principal Investigator:Gerhard Ehninger, MD University Hospital Carl Gustav Carus Dresden

nach 1. Induktionstherapie

8 Item-grupper 79 Dataelement

Ersterhebung

7 Item-grupper 38 Dataelement

2. Induktionstherapie - Unerwünschte Ereignisse CTC 3.0 -

2 Item-grupper 13 Dataelement

Diagnostik vor Therapiebeginn

4 Item-grupper 67 Dataelement

Induktionstherapie -Unerwünschte Ereignisse CTC 3.0-

2 Item-grupper 13 Dataelement

Eligibility criteria

2 Item-grupper 19 Dataelement

Eligibility Stem Cell Transplantation NCT00813124

- 2018-11-04 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); ODM derived from: https://clinicaltrials.gov/show/NCT00813124

Eligibility Acute Leukemias NCT01339988

- 2015-12-07 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT); ODM derived from: https://clinicaltrials.gov/show/NCT01339988

Eligibility Stem Cell Transplantation NCT00822770

- 2021-09-15 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin; ODM derived from: https://clinicaltrials.gov/show/NCT00822770

Eligibility Acute Lymphoblastic Leukaemia NCT01949129

- 2015-12-07 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia; ODM derived from: https://clinicaltrials.gov/show/NCT01949129

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial